In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

通过深度学习技术，研究者对22种高分化胎盘哺乳动物的基因组比对数据进行分析，推断了重组景观的演化历程。他们鉴定出一个占据X染色体30%长度、在演化中高度保守的大型连锁重组基因沙漠。

HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development ...

Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...

Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a Centene company , has designated CommUnityCare Health Centers and Dell Children's Medical Group Primary Care ...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and ...

New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights Parse Biosciences, the leading provider of accessible and scalable ...

TEL AVIV, Israel & LEHI, Utah & HOUSTON & FREMONT, Calif.--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today a landmark move to Whole Genome ...